CD4 and neoplasm: Regulatory T cells (Tregs) are a crucial subset of CD4+ T cells expressing FOXP3, which mediate immune tolerance by suppressing immune response against self‐antigens as well as tumor antigens.[97] In the context of TME a relatively high ratio of Tregs to effector T cells suppresses anti‐tumor immunity, promoting tumor progression.